Works by Mangiacavalli, Silvia

Results: 43
    1

    Monoclonal gammopathy of undetermined significance: a new proposal of workup.

    Published in:
    European Journal of Haematology, 2013, v. 91, n. 4, p. 356, doi. 10.1111/ejh.12172
    By:
    • Mangiacavalli, Silvia;
    • Cocito, Federica;
    • Pochintesta, Lara;
    • Pascutto, Cristiana;
    • Ferretti, Virginia;
    • Varettoni, Marzia;
    • Zappasodi, Patrizia;
    • Pompa, Alessandra;
    • Landini, Benedetta;
    • Cazzola, Mario;
    • Corso, Alessandro
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9

    Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma.

    Published in:
    Leukemia & Lymphoma, 2010, v. 51, n. 2, p. 236, doi. 10.3109/10428190903452826
    By:
    • Corso, Alessandro;
    • Barbarano, Luciana;
    • Mangiacavalli, Silvia;
    • Spriano, Mauro;
    • Alessandrino, Emilio P.;
    • Cafro, Anna Maria;
    • Pascutto, Cristiana;
    • Varettoni, Marzia;
    • Bernasconi, Paolo;
    • Grillo, Giovanni;
    • Carella, Angelo M.;
    • Montalbetti, Luigi;
    • Lazzarino, Mario;
    • Morra, Enrica
    Publication type:
    Article
    10

    P970: A REAL‐WORLD RETROSPECTIVE‐PROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF COMBINED IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE NORTHERN ITALY EXPERIENCE.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970784.08128.cd
    By:
    • Furlan, Anna;
    • Cea, Michele;
    • Zambello, Renato;
    • Pavan, Laura;
    • Galli, Monica;
    • Clissa, Cristina;
    • Mangiacavalli, Silvia;
    • Maria Cafro, Anna;
    • Girlanda, Stefania;
    • Patriarca, Francesca;
    • Minotto, Claudia;
    • Bertoldero, Giovanni;
    • Barilà, Gregorio;
    • Pascarella, Anna;
    • Lico, Albana;
    • Paolini, Rossella;
    • Rabassi, Nicholas;
    • Pescosta, Norbert;
    • Porrazzo, Marika;
    • Gherlinzoni, Filippo
    Publication type:
    Article
    11

    P823: BONE MARROW‐FREE SEQUENCING OF M PROTEIN GENES IN MONOCLONAL GAMMOPATHIES.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970196.90305.1f
    By:
    • Nevone, Alice;
    • Mazzini, Giulia;
    • Milani, Paolo;
    • Mangiacavalli, Silvia;
    • Melati, Anna;
    • Scanavino, Giulia;
    • Girelli, Maria;
    • Caminito, Serena;
    • Basset, Marco;
    • Cartia, Claudio;
    • Benvenuti, Pietro;
    • Nanci, Martina;
    • Bellofiore, Claudia;
    • Foli, Andrea;
    • Merlini, Giampaolo;
    • Arcaini, Luca;
    • Palladini, Giovanni;
    • Nuvolone, Mario
    Publication type:
    Article
    12

    Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.

    Published in:
    2021
    By:
    • Varettoni, Marzia;
    • Mangiacavalli, Silvia;
    • Rattotti, Sara;
    • Cartia, Claudio Salvatore;
    • Cavalloni, Chiara;
    • Rossetti, Franca;
    • Ferretti, Virginia Valeria;
    • Bergamini, Fabio;
    • Trotti, Chiara;
    • Fiorelli, Nicolas;
    • Pagani, Giuseppina;
    • Zerbi, Caterina;
    • Ferrari, Jacqueline;
    • Cristinelli, Caterina;
    • Muzzi, Alba;
    • Marena, Carlo;
    • Baldanti, Fausto;
    • Bruno, Raffaele;
    • Arcaini, Luca
    Publication type:
    Letter
    13
    14
    15
    16
    17
    18
    19
    20

    Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 11, p. 2485, doi. 10.3109/10428194.2013.779689
    By:
    • Varettoni, Marzia;
    • Zibellini, Silvia;
    • Capello, Daniela;
    • Arcaini, Luca;
    • Rossi, Davide;
    • Pascutto, Cristiana;
    • Rattotti, Sara;
    • Mangiacavalli, Silvia;
    • Pochintesta, Lara;
    • Gotti, Manuel;
    • Gaidano, Gianluca;
    • Cazzola, Mario
    Publication type:
    Article
    21
    22
    23

    Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analysis

    Published in:
    Mediterranean Journal of Hematology & Infectious Diseases, 2024, v. 16, n. 1, p. 1, doi. 10.4084/MJHID.2024.049
    By:
    • Cavallaro, Gianluca;
    • Paris, Laura;
    • Stefanoni, Paola;
    • Pavoni, Chiara;
    • Mangiacavalli, Silvia;
    • Cartia, Claudio Salvatore;
    • Pompa, Alessandra;
    • Cafro, Anna Maria;
    • Luisa Pioltelli, Maria;
    • Pezzatti, Sara;
    • Crippa, Stefano;
    • Rambaldi, Alessandro;
    • Galli, Monica
    Publication type:
    Article
    24

    Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab‐Refractory Multiple Myeloma Patients: A Multicenter Real‐World Study.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 2, p. 1, doi. 10.1002/hon.70042
    By:
    • Martino, Enrica Antonia;
    • Derudas, Daniele;
    • Rossi, Elena;
    • Stefanoni, Paola;
    • Mangiacavalli, Silvia;
    • Zamagni, Elena;
    • Offidani, Massimo;
    • Furlan, Anna;
    • Quinto, Angela Maria;
    • Della Pepa, Roberta;
    • Bertuglia, Giuseppe;
    • Barbieri, Emiliano;
    • Conticello, Concetta;
    • De Magistris, Claudio;
    • Bongarzoni, Velia;
    • Cafro, Anna Maria;
    • Mele, Anna;
    • Botta, Cirino;
    • Sgherza, Nicola;
    • Mele, Giuseppe
    Publication type:
    Article
    25

    Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow‐up of a multicenter, retrospective real‐world experience with 321 cases outside of controlled clinical trials.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3290
    By:
    • Martino, Enrica Antonia;
    • Palmieri, Salvatore;
    • Galli, Monica;
    • Derudas, Daniele;
    • Mina, Roberto;
    • Della Pepa, Roberta;
    • Zambello, Renato;
    • Vigna, Ernesto;
    • Bruzzese, Antonella;
    • Mangiacavalli, Silvia;
    • Zamagni, Elena;
    • Califano, Catello;
    • Musso, Maurizio;
    • Conticello, Concetta;
    • Cerchione, Claudio;
    • Mele, Giuseppe;
    • Di Renzo, Nicola;
    • Offidani, Massimo;
    • Tarantini, Giuseppe;
    • Casaluci, Gloria Margiotta
    Publication type:
    Article
    26

    A real‐life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3289
    By:
    • Bellofiore, Claudia;
    • Benvenuti, Pietro;
    • Mina, Roberto;
    • Basset, Marco;
    • Foli, Andrea;
    • Nanci, Martina;
    • Nuvolone, Mario;
    • Guida, Gianluigi;
    • Attanasio, Andrea;
    • Mussinelli, Roberta;
    • Mangiacavalli, Silvia;
    • Cartia, Claudio Salvatore;
    • Masoni, Valeria;
    • Palumbo, Michele;
    • Cani, Lorenzo;
    • Oliva, Stefania;
    • Consoli, Ugo;
    • Conticello, Concetta;
    • Di Raimondo, Francesco;
    • Arcaini, Luca
    Publication type:
    Article
    27

    Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 4, p. 704, doi. 10.1002/hon.3031
    By:
    • Bruzzese, Antonella;
    • Derudas, Daniele;
    • Galli, Monica;
    • Martino, Enrica Antonia;
    • Rocco, Stefano;
    • Conticello, Concetta;
    • Califano, Catello;
    • Giuliani, Nicola;
    • Mangiacavalli, Silvia;
    • Farina, Giuliana;
    • Lombardo, Alessandra;
    • Brunori, Marino;
    • Rossi, Elena;
    • Antonioli, Elisabetta;
    • Ria, Roberto;
    • Zambello, Renato;
    • Di Renzo, Nicola;
    • Mele, Giuseppe;
    • Marcacci, Gianpaolo;
    • Pietrantuono, Giuseppe
    Publication type:
    Article
    28
    29

    Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study).

    Published in:
    Annals of Hematology, 2019, v. 98, n. 2, p. 361, doi. 10.1007/s00277-018-3524-1
    By:
    • Musto, Pellegrino;
    • Villani, Oreste;
    • Pietrantuono, Giuseppe;
    • D'Arena, Giovanni;
    • Mansueto, Giovanna;
    • Di Renzo, Nicola;
    • Reddiconto, Giovanni;
    • Fragasso, Alberto;
    • Caravita, Tommaso;
    • Scapicchio, Daniele;
    • Marziano, Gioacchino;
    • Mangiacavalli, Silvia;
    • Corso, Alessandro;
    • Simeon, Vittorio;
    • Cascavilla, Nicola;
    • Falcone, Antonietta;
    • Petrucci, Maria Teresa;
    • Cesini, Laura;
    • Di Raimondo, Francesco;
    • Conticello, Concetta
    Publication type:
    Article
    30
    31

    A real‐world retrospective–prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7071
    By:
    • Furlan, Anna;
    • Cea, Michele;
    • Pavan, Laura;
    • Galli, Monica;
    • Clissa, Cristina;
    • Mangiacavalli, Silvia;
    • Cafro, Anna Maria;
    • Girlanda, Stefania;
    • Patriarca, Francesca;
    • Minotto, Claudia;
    • Bertoldero, Giovanni;
    • Barilà, Gregorio;
    • Pascarella, Anna;
    • Lico, Albana;
    • Paolini, Rossella;
    • Rabassi, Nicholas;
    • Pescosta, Norbert;
    • Porrazzo, Marika;
    • De Sabbata, Giovanni;
    • Pompa, Alessandra
    Publication type:
    Article
    32

    Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.890376
    By:
    • Morabito, Fortunato;
    • Zamagni, Elena;
    • Conticello, Concetta;
    • Pavone, Vincenzo;
    • Palmieri, Salvatore;
    • Bringhen, Sara;
    • Galli, Monica;
    • Mangiacavalli, Silvia;
    • Derudas, Daniele;
    • Rossi, Elena;
    • Ria, Roberto;
    • Catalano, Lucio;
    • Tacchetti, Paola;
    • Mele, Giuseppe;
    • Vincelli, Iolanda Donatella;
    • Martino, Enrica Antonia;
    • Vigna, Ernesto;
    • Bruzzese, Antonella;
    • Mendicino, Francesco;
    • Botta, Cirino
    Publication type:
    Article
    33
    34

    A risk‐stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders

    Published in:
    British Journal of Haematology, 2019, v. 187, n. 4, p. 441, doi. 10.1111/bjh.16086
    By:
    • Varettoni, Marzia;
    • Zibellini, Silvia;
    • Boveri, Emanuela;
    • Klersy, Catherine;
    • Candido, Chiara;
    • Rattotti, Sara;
    • Ferretti, Virginia V.;
    • Defrancesco, Irene;
    • Mangiacavalli, Silvia;
    • Nizzoli, Maria E.;
    • Flospergher, Elena;
    • Zerbi, Caterina;
    • Bergamini, Fabio;
    • Benvenuti, Pietro;
    • Brociner, Marco;
    • Merati, Gabriele;
    • Paulli, Marco;
    • Arcaini, Luca
    Publication type:
    Article
    35
    36
    37
    38

    Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients.

    Published in:
    European Journal of Haematology, 2022, v. 108, n. 3, p. 178, doi. 10.1111/ejh.13723
    By:
    • Morabito, Fortunato;
    • Zamagni, Elena;
    • Conticello, Concetta;
    • Pavone, Vincenzo;
    • Palmieri, Salvatore;
    • Bringhen, Sara;
    • Galli, Monica;
    • Mangiacavalli, Silvia;
    • Derudas, Daniele;
    • Rossi, Elena;
    • Ria, Roberto;
    • Catalano, Lucio;
    • Tacchetti, Paola;
    • Mele, Giuseppe;
    • Donatella Vincelli, Iolanda;
    • Antonia Martino, Enrica;
    • Vigna, Ernesto;
    • Botta, Cirino;
    • Bruzzese, Antonella;
    • Mele, Anna
    Publication type:
    Article
    39

    Limited Feasibility of Double Transplant in Multiple Myeloma.

    Published in:
    Cancer (0008543X), 2007, v. 109, n. 11, p. 2273, doi. 10.1002/cncr.22660
    By:
    • Corso, Alessandro;
    • Mangiacavalli, Silvia;
    • Barbarano, Luciana;
    • Alessandrino, Emilio Paolo;
    • Cairoli, Roberto;
    • Morra, Enrica;
    • Lazzarino, Mario
    Publication type:
    Article
    40
    41
    42
    43

    Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experience.

    Published in:
    2001
    By:
    • Castagnola, Carlo;
    • Alessandrino, Emilio Paolo;
    • Lunghi, Monia;
    • Bernasconi, Paolo;
    • Della Porta, Matteo;
    • Mangiacavalli, Silvia;
    • Colombo, Anna;
    • Corso, Alessandro;
    • Pagnucco, Guido;
    • Lazzarino, Mario;
    • Bernasconi, Carlo;
    • Castagnola, C;
    • Alessandrino, E P;
    • Lunghi, M;
    • Bernasconi, P;
    • Della Porta, M;
    • Mangiacavalli, S;
    • Colombo, A;
    • Corso, A;
    • Pagnucco, G
    Publication type:
    journal article